A Dual Enhancing Strategy of Novel Nanovaccine Based on TIM3 Silencing Nanoadjuvants and Desialylated Cancer Cell Membrane Antigens for Personalized Vaccination Immunotherapy of Cancer
Kaiming Li(China Pharmaceutical University), Huae Xu(China Pharmaceutical University)
Cited by 6
Related Papers
Immunostimulant In Situ Hydrogel Improves Synergetic Radioimmunotherapy of Malignant Glioblastoma Relapse Post‐Resection
|Advanced Functional Materials|2022|52
Deguelin induces the apoptosis of lung cancer cells through regulating a ROS driven Akt pathway
|Cancer Cell International|2015|33